Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase III, Uncontrolled Trial to Assess the Non-immunogenicity and Safety of Org 36286 in Patients Undergoing Repeated Controlled Ovarian Stimulation Cycles Using a Multiple Dose GnRH Antagonist Protocol
Brief Summary: The objective of the trial is to assess the non-immunogenicity and safety of corifollitropin alfa (also known as Org 36286, SCH 900962 and MK-8962) in participants undergoing repeated COS cycles using a multiple dose GnRH antagonist protocol.


Options:
A: Arm Label: corifollitropin alfa + recFSH Mothers; Type: N/A; Interventions: Drug: corifollitropin alfa, Biological: recombinant Follicle Stimulating Hormone (recFSH), Biological: hCG Bolus injection | Arm Label: corifollitropin alfa + hCG Mothers; Type: N/A; Interventions: Drug: corifollitropin alfa, Biological: human Chorion Gonadotropin (hCG), Biological: hCG Bolus injection | Intervention Type: DRUG; Name: corifollitropin alfa; Assigned to Arm(s): corifollitropin alfa + hCG Mothers, corifollitropin alfa + recFSH Mothers | Intervention Type: BIOLOGICAL; Name: recombinant Follicle Stimulating Hormone (recFSH); Assigned to Arm(s): corifollitropin alfa + recFSH Mothers | Intervention Type: BIOLOGICAL; Name: human Chorion Gonadotropin (hCG); Assigned to Arm(s): corifollitropin alfa + hCG Mothers | Intervention Type: BIOLOGICAL; Name: hCG Bolus injection; Assigned to Arm(s): corifollitropin alfa + hCG Mothers, corifollitropin alfa + recFSH Mothers
B: Arm Label: Experimental Group 1; Type: N/A; Interventions: Drug: Org 36286 | Arm Label: Experimental Group 2; Type: N/A; Interventions: Drug: recFSH | Intervention Type: DRUG; Name: Org 36286; Assigned to Arm(s): Experimental Group 1 | Intervention Type: DRUG; Name: recFSH; Assigned to Arm(s): Experimental Group 2
C: Arm Label: Corifollitropin alfa 150 µg; Type: EXPERIMENTAL; Interventions: Drug: Corifollitropin alfa, Biological: FSH, Biological: GnRH antagonist, Biological: (rec)hCG, Drug: Progesterone | Intervention Type: DRUG; Name: Corifollitropin alfa; Assigned to Arm(s): Corifollitropin alfa 150 µg | Intervention Type: BIOLOGICAL; Name: FSH; Assigned to Arm(s): Corifollitropin alfa 150 µg | Intervention Type: BIOLOGICAL; Name: GnRH antagonist; Assigned to Arm(s): Corifollitropin alfa 150 µg | Intervention Type: BIOLOGICAL; Name: (rec)hCG; Assigned to Arm(s): Corifollitropin alfa 150 µg | Intervention Type: DRUG; Name: Progesterone; Assigned to Arm(s): Corifollitropin alfa 150 µg
D: Arm Label: 150 µg Corifollitropin Alfa; Type: N/A; Interventions: Drug: 150 µg Corifollitropin Alfa, Drug: Placebo for RecFSH/Follitropin beta, Biological: 200 IU RecFSH/Follitropin beta (Days 8 to hCG), Drug: Ganirelix, Biological: hCG, Biological: Progesterone | Arm Label: 200 IU RecFSH; Type: N/A; Interventions: Biological: 200 IU RecFSH/Follitropin beta (Days 1 to 7), Drug: Placebo for Corifollitropin Alfa, Biological: 200 IU RecFSH/Follitropin beta (Days 8 to hCG), Drug: Ganirelix, Biological: hCG, Biological: Progesterone | Intervention Type: DRUG; Name: 150 µg Corifollitropin Alfa; Assigned to Arm(s): 150 µg Corifollitropin Alfa | Intervention Type: BIOLOGICAL; Name: 200 IU RecFSH/Follitropin beta (Days 1 to 7); Assigned to Arm(s): 200 IU RecFSH | Intervention Type: DRUG; Name: Placebo for Corifollitropin Alfa; Assigned to Arm(s): 200 IU RecFSH | Intervention Type: DRUG; Name: Placebo for RecFSH/Follitropin beta; Assigned to Arm(s): 150 µg Corifollitropin Alfa | Intervention Type: BIOLOGICAL; Name: 200 IU RecFSH/Follitropin beta (Days 8 to hCG); Assigned to Arm(s): 150 µg Corifollitropin Alfa, 200 IU RecFSH | Intervention Type: DRUG; Name: Ganirelix; Assigned to Arm(s): 150 µg Corifollitropin Alfa, 200 IU RecFSH | Intervention Type: BIOLOGICAL; Name: hCG; Assigned to Arm(s): 150 µg Corifollitropin Alfa, 200 IU RecFSH | Intervention Type: BIOLOGICAL; Name: Progesterone; Assigned to Arm(s): 150 µg Corifollitropin Alfa, 200 IU RecFSH

Answer: C